The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.75
Bid: 32.50
Ask: 33.00
Change: -0.25 (-0.76%)
Spread: 0.50 (1.538%)
Open: 32.75
High: 33.00
Low: 32.50
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Follow-On Investment into Existing Royalty Partner

27 Oct 2021 07:01

RNS Number : 3564Q
Duke Royalty Limited
27 October 2021
 

27 October 2021

 

Duke Royalty Limited

 

("Duke Royalty", "Duke" or the "Company")

 

£4.2 million Follow-On Investment into Existing Royalty Partner

Duke Royalty (AIM:DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has conditionally agreed a follow-on investment of approximately £4.2 million ("the Financing") into its existing royalty partner, Bakhchysarai (Ireland) Limited ("BIL"), to fund its latest acquisition.

BIL is the investment holding company created to execute a buy and build strategy of synergistic companies within the Irish/UK recruitment sector. Its current holdings include Brightwater Selection (Ireland) Limited ("Brightwater") and PharmEng Limited ("PE Global").

Duke's new capital will provide financing for BIL's third acquisition, Vantage Resources Limited ("Vantage"), an IT contracting and talent acquisition business that sources specialist IT professionals on medium to long term contracts to a range of major Irish organisations.

Highlights:

 

· Duke's latest investment in BIL would increase its total exposure to approximately £13.6 million (€16.0m)

· Initial cash yield of 13.5% per annum on the new investment via monthly payments, which commence immediately following the provision of the funds by Duke, expected in Q4 2021

· Vantage was incorporated in 2000 and has a longstanding history of profitable operations

· The addition of Vantage increases BIL's sector and end-customer diversification

· The investment remains subject to approval from The Competition and Consumer Protection Commission, which is the competition regulator responsible for enforcing Irish and European competition law in the Republic of Ireland. Once the expected approvals are granted, currently anticipated in Q4 2021, the Duke funding will complete

· Duke retains its 30% equity interest in BIL

 

Neil Johnson, CEO of Duke Royalty, said:

"We are delighted that BIL has acquired Vantage, which is expected to improve profitability and add diversification to the business. Vantage has a longstanding and impressive blue chip client base, which speaks to the quality of its service offering.

"A core part of Duke's investment mandate is to provide existing royalty partners with the capital to undertake complementary M&A transactions due to its ability to increase our monthly distributions from trusted partners. Duke continues to enjoy a successful partnership with BIL, supporting its buy and build strategy, and we look forward to continuing our close work."

 

Further information regarding Vantage

Vantage Resources Limited is an IT contracting and talent acquisition business that primarily sources specialist IT professionals on medium to long term contracts to clients. The company's service offerings include IT Contracting, Testing, Quality Assurance (QA) and Project management with a particular focus on clients in the Government, Financial Services and ICT segments.

Vantage has a longstanding client base with many of Ireland's top 100 companies relying on it to source, acquire and retain professional IT talent.

About the Financing

BIL became a royalty partner via Duke's acquisition of UK-based royalty finance provider, Capital Step Holdings Limited, in February 2019. Subsequently, as part of the PE Global acquisition completed in January 2020, the entire BIL investment was refinanced in line with Duke's typical investment terms. This further conditional financing of £4.2 million is expected to be implemented via an addendum to the existing agreement between Duke and BIL, with the increased investment effected through a combination of a secured loan and preference shares.

In line with Duke's other investments, and reflective of the participating nature of the Duke investment, the regular distribution payments owed to Duke by BIL will be adjusted annually based on the percentage change in total combined Net Fee Income of BIL compared to its prior financial (calendar) year. The annual adjustment in the distribution will be subject to an agreed collar, in line with Duke's typical terms.

Since no additional equity is being raised as a part of the Financing, Duke retains its 30% equity interest in BIL.

Duke Royalty Portfolio

A full list of Duke's current Royalty Partners are now included for reference on the Partners page of our website: www.dukeroyalty.com/partners.

 

This announcement contains inside information.

 

***ENDS***

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

 

 

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/ Richard Bicknell/ Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMFBTTMTBTTBB
Date   Source Headline
22nd Jun 20173:19 pmRNSFinal Results and Maiden Dividend
22nd Jun 20177:00 amRNSFinal Results
9th Jun 20177:00 amRNSRoyalty Partner Operational Update
6th Apr 20177:00 amRNSInaugural royalty financing agreement
28th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 20172:55 pmRNSHolding(s) in Company
23rd Mar 20175:00 pmRNSRe-Admission and First Day of Dealings
22nd Mar 20173:45 pmRNSSch 1 Update - Duke Royalty Limited
20th Mar 20179:35 amRNSSch 1 Update - Duke Royalty Limited
17th Mar 20176:17 pmRNSResult of Fundraising
16th Mar 20175:03 pmRNSProposed Placing and Subscription
21st Feb 201711:25 amRNSSch 1 Update - Duke Royalty Limited
1st Feb 201711:00 amRNSSchedule 1 - Duke Royalty Limited
11th Jan 20177:01 amRNSAppointment of Chief Investment Officer
11th Jan 20177:00 amRNSChange of Advisors and Operational Update
17th Nov 20169:00 amRNSUnaudited interim results
1st Sep 201612:02 pmRNSResult of AGM
25th Jul 20167:00 amRNSFinal Results
29th Mar 20161:32 pmRNSSale of investments
7th Mar 20167:00 amRNSBoard Changes and Corporate Update
3rd Feb 20167:00 amRNSDirector/PDMR Shareholding
19th Jan 20169:55 amRNSChange of Adviser
14th Dec 201511:40 amRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim results
29th Oct 20157:00 amRNSHolding(s) in Company
29th Oct 20157:00 amRNSCorrection: Appointment and Issue of Shares
28th Oct 20157:00 amRNSMr Justin Cochrane Appointment and Issue of Shares
12th Oct 20155:16 pmRNSHolding(s) in Company
17th Sep 20153:40 pmRNSFormation of Healthcare Investment Committee
14th Sep 201512:41 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSDirector share purchase
10th Sep 201512:00 pmRNSResult of AGM
7th Sep 20159:15 amRNSGrant of options
7th Sep 20157:00 amRNSPlacing
7th Sep 20157:00 amRNSCollaboration with Oliver Wyman
4th Aug 201512:21 pmRNSChanges to NAV Reporting
27th Jul 20154:12 pmRNSResults for the year ended 31 March 2015
16th Jun 201511:36 amRNSResult of EGM
10th Jun 201511:21 amRNSHolding(s) in Company
2nd Jun 20151:57 pmRNSHolding(s) in Company
28th May 201511:00 amRNSEGM, proposed changes to board & investing policy
26th May 20159:58 amRNSHolding(s) in Company
26th May 20159:57 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
22nd May 20155:15 pmRNSRepayment of zero dividend preference shares
20th May 20157:00 amRNSPlacing
15th May 201511:08 amRNSSale of investment
20th Apr 20155:36 pmRNSNet Asset Value(s)
19th Jan 20154:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.